At Goodwin in Cambridge, ‘the team provides timely, pragmatic and and commercial advice’ and clients note that the lawyers are ‘accessible, responsive and keen to understand our aims’. David Mardle has broad expertise in life sciences, technology, M&A, and finance matters; commercial IP specialist Malcolm Bates, who has ‘broad and long experience' in R&D projects and collaboration agreements; and licensing and contracts expert Tim Worden are key to the practice. Worden acted as part of a multinational team to advise Biocon Biologics on its multibillion-dollar acquisition of the global biosimilars business of its partner Viatris Inc. Up-and-coming partner Elizabeth Rhodes handles corporate and venture capital matters for technology and life sciences companies.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The team provides timely, pragmatic and and commercial advice on our licensing activities which we find very valuable. They are accessible, responsive and keen to understand our aims during transactions and regularly help us navigate complex scenarios given their knowledge and expertise in the market.’
‘Tim Worden provides us with expert coverage as our key contact as well as high quality, deal-specific advice on our licensing activities. He has pulled in trans-Atlantic resources on deals when we have needed it seamlessly and delivers a really high-quality service.'
‘We work especially with Malcolm Bates. Malcolm's broad and long experience makes interactions and processes run smoothly and efficiently.’
Key clients
- Biocon Biologics
- Syndesi Therapeutics
- Okrai.ai
- Refeyn Limited
- Oxford Science Enterprises PLC
- Engitix Therapeutics
- Synaffix BV
- Stalicla SA
- Ten Eleven Ventures III, LP
- MiroBio Ltd
- SV Health Investors
- CMR Surgical
- Ochre Bio, Inc
- Gadeta
Work highlights
- Advised Biocon Biologics Ltd on its multi-billion-dollar acquisition of the global biosimilars business of its partner Viatris Inc.
Advised Synaffix B.V on three license agreements: with Genmab A/S; with Amgen Inc; with Hummingbird Bioscience.
- Advised Stalicla SA on an in-licensing agreement with Novartis.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
The lawyer(s) leading their teams.
Malcolm Bates, David Mardle, Tim Worden